Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-01 Purchase |
2023-02-02 2:49 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
400 | $3.1034 | $1,241 | 522,859 (Direct) |
View |
| 2023-01-27 Purchase |
2023-01-30 09:33 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
200 | $3.01 | $602 | 522,459 (Direct) |
View |
| 2023-01-20 Purchase |
2023-01-24 12:27 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
200 | $3.135 | $627 | 522,259 (Direct) |
View |
| 2023-01-18 Purchase |
2023-01-20 08:19 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
400 | $3.1108 | $1,244 | 522,059 (Direct) |
View |
| 2023-01-09 Purchase |
2023-01-10 6:06 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
100 | $3.08 | $308 | 521,659 (Direct) |
View |
| 2022-12-23 Purchase |
2022-12-28 08:22 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
300 | $3.01 | $903 | 521,559 (Direct) |
View |
| 2022-12-07 Purchase |
2022-12-07 6:04 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
1,800 | $2.9861 | $5,375 | 521,259 (Direct) |
View |
| 2022-11-21 Purchase |
2022-11-21 5:14 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
943 | $2.6162 | $2,467 | 513,801 (Indirect Direct) |
View |
| 2022-11-18 Purchase |
2022-11-21 07:49 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
1,000 | $2.8765 | $2,877 | 519,459 (Direct) |
View |
| 2022-10-12 Purchase |
2022-10-12 2:01 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
725 | $3.3884 | $2,457 | 512,858 (Indirect Direct) |
View |
| 2022-10-11 Purchase |
2022-10-12 08:54 am |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
806 | $3.6886 | $2,973 | 512,133 (Indirect Direct) |
View |
| 2022-09-23 Purchase |
2022-09-27 5:23 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
300 | $2.8299 | $849 | 617,204 (Indirect Direct) |
View |
| 2022-09-22 Purchase |
2022-09-23 09:55 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
200 | $2.92 | $584 | 518,459 (Direct) |
View |
| 2022-08-26 Purchase |
2022-09-09 6:17 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
5,723 | $3.2809 | $18,777 | 511,327 (Indirect Direct) |
View |
| 2022-08-26 Sale |
2022-09-09 6:17 pm |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
3,958 | $3.388 | $13,410 | 511,327 (Indirect Direct) |
View |
| 2022-07-06 Purchase |
2022-07-15 11:46 am |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
1,200 | $3.0092 | $3,611 | 616,904 (Indirect Direct) |
View |
| 2022-07-12 Purchase |
2022-07-13 08:25 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
700 | $2.95 | $2,065 | 518,259 (Direct) |
View |
| 2022-06-30 Purchase |
2022-07-05 6:10 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
1,900 | $3.0789 | $5,850 | 615,704 (Indirect Direct) |
View |
| 2022-06-30 Purchase |
2022-07-01 09:20 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
1,100 | $3.0981 | $3,408 | 517,559 (Direct) |
View |
| 2022-06-17 Purchase |
2022-06-23 3:42 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
700 | $3.7856 | $2,650 | 613,804 (Indirect Direct) |
View |
| 2022-06-15 Purchase |
2022-06-17 5:05 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
3,200 | $3.7734 | $12,075 | 613,104 (Indirect Direct) |
View |
| 2022-06-16 Purchase |
2022-06-17 4:02 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
600 | $3.73 | $2,238 | 516,459 (Direct) |
View |
| 2022-06-15 Purchase |
2022-06-15 5:50 pm |
BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer |
194 | $3.61 | $700 | 18,484 (Direct) |
View |
| 2022-06-15 Purchase |
2022-06-15 5:30 pm |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
700 | $3.6822 | $2,578 | 515,859 (Direct) |
View |
| 2022-06-13 Purchase |
2022-06-15 4:45 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
1,300 | $3.9204 | $5,097 | 609,904 (Indirect Direct) |
View |
| 2022-06-14 Purchase |
2022-06-15 11:01 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
500 | $3.9119 | $1,956 | 515,159 (Direct) |
View |
| 2022-06-13 Purchase |
2022-06-14 11:55 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
200 | $3.95 | $790 | 514,659 (Direct) |
View |
| 2022-06-09 Purchase |
2022-06-13 3:33 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
1,600 | $4.2536 | $6,806 | 608,604 (Indirect Direct) |
View |
| 2022-06-07 Purchase |
2022-06-09 4:42 pm |
BioRestorative Therapies Inc. | BRTX | Broadrick Dale 10% Owner |
6,000 | $4.5664 | $27,398 | 607,004 (Indirect Direct) |
View |
| 2022-06-08 Purchase |
2022-06-09 11:41 am |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
100 | $4.28 | $428 | 514,459 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-02-17 Option Award |
2023-02-17 5:29 pm |
N/A 2033-02-17 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development 10% Owner |
106,762 | $0 | 620,562 (Direct) |
View |
| 2023-02-17 Option Award |
2023-02-17 5:27 pm |
N/A 2033-02-17 |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB 10% Owner |
106,762 | $0 | 629,621 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-04 4:28 pm |
N/A 2031-11-04 |
BioRestorative Therapies Inc. | BRTX | Paccasassi Robert VP, QA and Reg Compliance |
8,277 | $0 | 8,277 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-04 4:27 pm |
N/A 2031-03-18 |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
335,538 | $0 | 512,858 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-04 4:24 pm |
N/A 2031-11-04 |
BioRestorative Therapies Inc. | BRTX | Kristal Robert Eugene Chief Financial Officer |
10,490 | $0 | 18,484 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-04 4:22 pm |
N/A 2031-11-04 |
BioRestorative Therapies Inc. | BRTX | Kukekov Nickolay V. Director |
25,236 | $0 | 25,236 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-04 4:19 pm |
N/A 2031-11-04 |
BioRestorative Therapies Inc. | BRTX | Williams Patrick F. Director |
10,490 | $0 | 10,490 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-04 4:18 pm |
N/A 2031-11-04 |
BioRestorative Therapies Inc. | BRTX | Rosa David A Director |
10,490 | $0 | 10,490 (Direct) |
View |
| 2022-11-03 Option Award |
2022-11-04 4:16 pm |
N/A 2031-03-18 |
BioRestorative Therapies Inc. | BRTX | ALSTODT LANCE President, CEO, COB |
335,538 | $0 | 518,459 (Direct) |
View |
| 2022-06-14 Option Award |
2022-06-15 2:55 pm |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
263 | $3.7774 | 509,563 (Direct) |
View |
| 2022-06-07 Option Award |
2022-06-08 09:37 am |
N/A N/A |
BioRestorative Therapies Inc. | BRTX | Silva Francisco VP of Research and Development |
565 | $4.6493 | 509,300 (Direct) |
View |